Zepp Health Corporation
ZEPP
$10.25
-$0.93-8.32%
NYSE
| 12/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 85.17M | 59.54M | 42.46M | 40.64M | 40.01M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 85.17M | 59.54M | 42.46M | 40.64M | 40.01M |
| Cost of Revenue | 50.75M | 37.61M | 25.22M | 24.28M | 25.29M |
| Gross Profit | 34.42M | 21.93M | 17.24M | 16.36M | 14.72M |
| SG&A Expenses | 27.30M | 19.81M | 18.92M | 15.41M | 17.17M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 89.04M | 68.48M | 55.00M | 50.51M | 55.85M |
| Operating Income | -3.87M | -8.94M | -12.54M | -9.87M | -15.84M |
| Income Before Tax | -8.90M | -23.33M | -13.26M | -10.80M | -14.66M |
| Income Tax Expenses | 2.07M | 13.57M | -- | 47.00K | 71.60K |
| Earnings from Continuing Operations | -10.97M | -36.90M | -13.26M | -10.85M | -14.73M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | 25.00K | 8.00K | 10.00K | 32.20K |
| Net Income | -10.97M | -36.88M | -13.25M | -10.84M | -14.70M |
| EBIT | -3.87M | -8.94M | -12.54M | -9.87M | -15.84M |
| EBITDA | -2.74M | -7.68M | -10.60M | -7.94M | -13.95M |
| EPS Basic | -11.06 | -36.70 | -13.13 | -10.65 | -14.50 |
| Normalized Basic EPS | -0.25 | -0.51 | -0.52 | -- | -0.64 |
| EPS Diluted | -11.70 | -36.70 | -13.13 | -10.65 | -14.62 |
| Normalized Diluted EPS | -0.25 | -0.51 | -0.52 | -- | -0.64 |
| Average Basic Shares Outstanding | 15.88M | 16.08M | 16.15M | 16.28M | 16.22M |
| Average Diluted Shares Outstanding | 992.30K | 1.00M | 1.01M | 1.02M | 1.01M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |